112 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
EC Ecopetrol S.A. $25.79 $53.02B Uptrend
Article Searches
EC OKs expanded use for Bristol-Myers' Sprycel https://seekingalpha.com/news/3431582-ec-oks-expanded-use-bristol-myers-sprycel?source=feed_news_all Feb 11, 2019 - The European Commission (EC) approves Bristol-Myers Squibb's (NYSE:BMY) Sprycel (dasatinib), combined with chemo, for the treatment pediatric patients with newly diagnosed Philadelphia chromos
Changes To Rules Sought After EC Rejects Siemens/Alstom Rail Merger http://feeds.benzinga.com/~r/benzinga/~3/jXz47VKeC7U/changes-to-rules-sought-after-ec-rejects-siemensalstom-rail-merger Feb 06, 2019 -

Germany will seek a reform of European Union (EU) competition regulations following the decision by the European Competition Directorate to reject Siemens' and Alstom's application to merge their rail businesses.

read more

Albireo granted Orphan Designation by EC for A4250 for treatment of biliary atresia https://seekingalpha.com/news/3417836-albireo-granted-orphan-designation-ec-a4250-treatment-biliary-atresia?source=feed_news_all Dec 18, 2018 - Albireo Pharma (NASDAQ:ALBO) announces the European Commission (EC) has granted orphan designation to A4250, an ileal bile acid transporter inhibitor, for the treatment of biliary atresia, a
EC OK's self-administration of Novartis' Xolair across all indications https://seekingalpha.com/news/3416676-ec-oks-self-administration-novartis-xolair-across-indications?source=feed_news_all Dec 13, 2018 - The European Commission (EC) has approved Novartis' (NYSE:NVS) Xolair (omalizumab) prefilled syringe for self-administration for patients with severe allergic asthma and chronic spontaneous ur
The Zacks Analyst Blog Highlights: Royal Dutch, Par Pacific, Precision Drilling, Petrobras and Ecopetrol http://www.zacks.com/stock/news/341269/the-zacks-analyst-blog-highlights-royal-dutch-par-pacific-precision-drilling-petrobras-and-ecopetrol?cid=CS-ZC-FT-341269 Dec 05, 2018 - The Zacks Analyst Blog Highlights: Royal Dutch, Par Pacific, Precision Drilling, Petrobras and Ecopetrol
Oil & Gas Stock Roundup: Shell's Green Initiative, Par Pacific's Acquisition & More http://www.zacks.com/stock/news/341123/oil-gas-stock-roundup-shells-green-initiative-par-pacifics-acquisition-more?cid=CS-ZC-FT-341123 Dec 04, 2018 - Royal Dutch Shell (RDS.A) became the first oil company to link executive pay with carbon emissions, while Par Pacific Holdings (PARR) entered into an acquisition to bolster its downstream operations.
The Daily Biotech Pulse: EC Nod For Shire, Mirati Gets FDA Clearance For Cancer Drug Trials, PhaseBio's First Earnings http://feeds.benzinga.com/~r/benzinga/~3/2GrT5jG_15A/the-daily-biotech-pulse-ec-nod-for-shire-mirati-gets-fda-clearance-fo Nov 30, 2018 -

Here's a roundup of top developments in the biotech space over the last 24 hours.

Scaling The Peak

(Biotech stocks hitting 52-week highs on Nov. 29)

read more

Stock Market News For Nov 28, 2018 http://www.zacks.com/stock/news/339739/stock-market-news-for-nov-28-2018?cid=CS-ZC--339739 Nov 28, 2018 - Wall Street closed sharply higher on Tuesday after comments from a top U.S. economic adviser raised hopes for a solution to the ongoing trade war with China
EC approves Spark Therapeutics’ LUXTURNA for inherited retinal disease caused by confirmed biallelic RPE65 mutations https://seekingalpha.com/news/3411807-ec-approves-spark-therapeutics-luxturna-inherited-retinal-disease-caused-confirmed-biallelic?source=feed_news_all Nov 23, 2018 - Spark Therapeutics (NASDAQ:ONCE) announces that the European Commission (EC) has granted marketing authorization for LUXTURNA (voretigene neparvovec), a one-time gene therapy for the treatmen
Ecopetrol SA (EC) CEO Felipe Pardo on Q3 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4217298-ecopetrol-sa-ec-ceo-felipe-pardo-q3-2018-results-earnings-call-transcript?source=feed_sector_transcripts Nov 01, 2018 - Ecopetrol SA (NYSE:EC) Q3 2018 Earnings Conference Call November 1, 2018, 10:30 ET Executives Maria Catalina - Head, Corporate Finance & IR & Head, Capital Markets Felipe Pardo - CEO Jorge Arc

Pages: 123456...12

Page 1>

Related Companies

Name Exchange Price Mkt Cap
OXY Occidental Petroleum Corporation NYSE $77.6 $59.34B
CNQ Canadian Natural Resources Limited NYSE $31.6 $38.59B
EOG EOG Resources, Inc. NYSE $117.54 $68.08B
E ENI S.p.A. NYSE $37.64 $68.4B
PBR Petroleo Brasileiro S.A.- Petrobras NYSE $10.92 $71.22B
Sector: Energy > Industry: Oil & Gas Production
DeepLinks for Ecopetrol S.A.
EC - Google Finance https://www.google.com/finance?q=EC Industry related info and international coverage Summary News
EC - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=EC Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options